Acquired von Willebrand's disease, cryoglobulinemia and pseudoanalbuminemia in monoclonal dysglobulinemia
Harlé, J.R.; Lefevre, P.; Pesquié, M.; Aillaud, M.F.; Dalmasso, C.; Boucraut, J.; Gulian, J.M.; Karsenti, J.M.; Bernard, D.; Charrel, M.
Presse Medicale 19(36): 1661-1664
1990
ISSN/ISBN: 0755-4982 PMID: 2147267 Document Number: 355673
The authors report an exceptional case of complex monoclonal dysglobulinaemia characterized by cryoglobulinaemia, pseudoanalbuminaemia and acquired type 1 Von Willebrand's disease. All these biological abnormalities are consecutive to the formation of molecular complexes in vivo. These complexes have also been found in vitro between albumin immunoglobulins G.
Document emailed within 1 workday
Related Documents
Mahapatra, M.; Mishra, P.; Makharia, G.; Kumar, R.; Saxena, R. 2006: Acquired von Willebrand's disease associated with gastrointestinal angiodysplasia and monoclonal gammopathy Journal of the Association of Physicians of India 54: 963Sørensen, P.J.; Dyerberg, J. 1981: Acquired von Willebrand's disease Ugeskrift for Laeger 143(11): 684
Takahashi, H.; Yamada, M.; Shibata, A. 1987: Acquired von Willebrand's disease in hypothyroidism Thrombosis and Haemostasis 58(4): 1095
Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274
Fukui, H.; Okuda, T.; Takase, T.; Mikami, S.; Yoshioka, A.; Fujimura, Y.; Yoshioka, K. 1978: Two cases of atypical von Willebrand's disease with inhibitory effect on von Willebrand factor Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 41(5): 897-907
Fukui, H.; Yoshioka, A.; Mikami, S.; Takase, T.; Fujimura, Y.; Takahashi, Y.; Nishino, M.; Iwagaki, K. 1979: Pathophysiology of von Willebrand's disease: Qualitative and quantitative analysis of von Willebrand protein Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 42(6): 839-850
Nichols, T.C.; Bellinger, D.A.; Reddick, R.L.; Read, M.S.; Koch, G.G.; Brinkhous, K.M.; Griggs, T.R. 1991: Role of von Willebrand factor in arterial thrombosis. Studies in normal and von Willebrand disease pigs Circulation 83(6): Iv56-Iv64
Piao, Y.C.; Lavergne, J.M.; Boyer-Neumann, C.; Schandelong, A.; Alessi, M.C.; Meyer, D. 1993: Arg578Gln mutations in the von Willebrand factor gene in three unrelated cases of type IIB von Willebrand disease Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 4(5): 787-789
Takahashi, H. 1981: Studies on the pathophysiology and treatment of von Willebrand's disease. II. Gel filtration studies on plasma factor VIIi in von Willebrand's disease Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 44(1): 165-172
Rastegar-Lari, G.; Ajzenberg, N.; Ribba, A.S.; Vereycken-Holler, V.; Legendre, P.; Villoutreix, B.; Meyer, D.; Baruch, D. 2001: Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations Thrombosis and Haemostasis 86(6): 1459-1465
Inbal, A.; Kornbrot, N.; Harrison, P.; Randi, A.M.; Sadler, J.E. 1993: Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor Thrombosis and Haemostasis 70(6): 1058-1062
Carrasco, M.; Anguita, T.; de la Cuadra, H.; Mocarquer, A.; Viveros, L.; Osorio, G.; Ampuero, N. 1984: Essential monoclonal cryoglobulinemia Revista Medica de Chile 112(11): 1149-1152
Gonzalez-Rodriguez, A.J.; Bella-Navarro, R.; Ramon Quiles, D.; Jorda-Cuevas, E. 2014: Acquired cutis laxa associated with monoclonal gammopathy and lambda light chain deposition disease Dermatology Online Journal 20(5): 22611
Foster, P.A. 1995: The reproductive health of women with von Willebrand Disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 74(2): 784-790
Abdi, S.; Bahji, M.; Essaadouni, L.; Agoumi, N..Benkirane.; Adnaoui, M.; Tazi, Z.Mezalek.; Maaouni, A. 2004: Mixed cryoglobulinemia with monoclonal IgA and biclonal IgM during hepatitis C virus infection Annales de Biologie Clinique 62(3): 334-337
Sultan, Y.; Simeon, J.; Caen, J.P. 1976: Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease Journal of Laboratory and Clinical Medicine 87(2): 185-194
Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Lethagen, S.; Isaksson, C.; Schaedel, C.; Holmberg, L. 2002: Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X) Thrombosis and Haemostasis 88(3): 421-426
Spertini, F.; Donati, Y.; Welle, I.; Izui, S.; Lambert, P.H. 1989: Prevention of murine cryoglobulinemia and associated pathology by monoclonal anti-idiotypic antibody Journal of Immunology 143(8): 2508-2513
Girma, J.P.; Pietu, G.; Lavergne, J.M.; Meyer, D.; Larrieu, M.J. 1982: Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease Journal of Laboratory and Clinical Medicine 99(4): 481-494